We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TDAC:NASDAQTranslational Development Acquisition Corp. Analysis

Data as of 2026-09-07 - not real-time

$10.85

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Translational Development Acquisition Corp. trades at $10.85, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. It has gained 1.0% over the past 30 days. With RSI at 57.6 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $10.82 and resistance around $10.89.
Multiples put this in overvalued territory: 41.7 times earnings against the sector's 16.5.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 3.0% and a beta of 0.02, position sizing matters here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is sell, conviction 4 out of 10.

Top Market Events

ProLogium And Translational Development Acquisition Corp.Investment consists of $50 million of committed capital from existing investors of ProLogium at the previously...Tärkeimmät ajankohtaiset talousuutiset, pörssikurssit ja kattavat sijoittajapalvelut löydät Kauppalehdestä.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 10.62
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 41.7 versus sector average of 16.5
  • Trading above the 200-day average of 10.62

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • P/E of 41.7 versus sector average of 16.5
  • Negative free cash flow
  • Thin trading liquidity raises execution risk

Key Metrics & Analysis

Financial Health

P/E Ratio41.7
ROA-0.49%
P/B Ratio-36.3
Op. Cash Flow$-849378
Free Cash Flow$-355048
Industry P/E16.5

Technical Analysis

TrendBullish
RSI57.6
Support$10.82
Resistance$10.89
MA 20$10.85
MA 50$10.79
MA 200$10.62
MACDBearish
VolumeDecreasing
Fear & Greed Index94.11

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.02
Volatility3.01%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.